ATL Stock Overview
Atlas Global Brands Inc. operates as a cannabis company in Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Atlas Global Brands Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.15 |
52 Week High | CA$1.50 |
52 Week Low | CA$0.14 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -86.36% |
Recent News & Updates
Recent updates
Shareholder Returns
ATL | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 0% | -0.1% | 0.8% |
1Y | n/a | 47.9% | 4.8% |
Return vs Industry: Insufficient data to determine how ATL performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ATL performed against the Canadian Market.
Price Volatility
ATL volatility | |
---|---|
ATL Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 13.8% |
Market Average Movement | 9.0% |
10% most volatile stocks in CA Market | 18.0% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ATL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ATL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Bernie Yeung | atlasglobalbrands.com |
Atlas Global Brands Inc. operates as a cannabis company in Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom. It is involved in cannabis cultivation, manufacturing, scalability, marketing, distribution, and pharmacy activities. The company is based in Chatham, Canada.
Atlas Global Brands Inc. Fundamentals Summary
ATL fundamental statistics | |
---|---|
Market cap | CA$23.80m |
Earnings (TTM) | CA$26.05m |
Revenue (TTM) | n/a |
0.9x
P/E Ratio0.0x
P/S RatioIs ATL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ATL income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | -CA$26.05m |
Earnings | CA$26.05m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.16 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 77.0% |
How did ATL perform over the long term?
See historical performance and comparison